Maxi Sacher1, Jürgen Meixensberger2, Wolfgang Krupp2. 1. Department of Neurosurgery, University Hospital of Leipzig, Liebigstraße 20, 04103, Leipzig, Germany. Maxi.Sacher@t-online.de. 2. Department of Neurosurgery, University Hospital of Leipzig, Liebigstraße 20, 04103, Leipzig, Germany.
Abstract
INTRODUCTION: Patients who are diagnosed with high-grade gliomas (HGG) have poor prognoses and often experience rapid declines in functional and cognitive status, which makes caring for them particularly stressful. We conducted a prospective study to investigate the factors influencing the quality of life of HGG patients and their informal caregivers and analyzed their reciprocal impacts. Based on our results, we elaborated a screening model to identify patients and caregivers in need of psychooncological support. METHODS: A total of 45 matched HGG patient-caregiver dyads completed the Multidimensional Mood State Questionnaire, the 12-Item Short Form Medical Outcome Questionnaire and the Center for Epidemiology Studies Depression Scale. A subsequent semi-structured interview was performed with each individual. RESULTS: We found a significant relationship between the mood and depression scores of patients and caregivers, with a third of them displaying symptoms of a major depressive episode. Our screening model showed that 73% of the dyads exhibited signs of severe emotional strain with the need of psychooncological support. Beneficial factors that helped patients and caregivers cope with the illness included mutual respect, good communication, caregiver mastery and resilience. CONCLUSIONS: For a more comprehensive understanding of patient-caregiver interactions, we recommend using a combination of standardized psychometric tests and a semi-structured interview. The high percentage of emotional strain and depression found in patients and their caregivers facing HGG highlights the necessity of methodical screening for warning signs and consequent initiation of psycho-oncological interventions.
INTRODUCTION:Patients who are diagnosed with high-grade gliomas (HGG) have poor prognoses and often experience rapid declines in functional and cognitive status, which makes caring for them particularly stressful. We conducted a prospective study to investigate the factors influencing the quality of life of HGG patients and their informal caregivers and analyzed their reciprocal impacts. Based on our results, we elaborated a screening model to identify patients and caregivers in need of psychooncological support. METHODS: A total of 45 matched HGG patient-caregiver dyads completed the Multidimensional Mood State Questionnaire, the 12-Item Short Form Medical Outcome Questionnaire and the Center for Epidemiology Studies Depression Scale. A subsequent semi-structured interview was performed with each individual. RESULTS: We found a significant relationship between the mood and depression scores of patients and caregivers, with a third of them displaying symptoms of a major depressive episode. Our screening model showed that 73% of the dyads exhibited signs of severe emotional strain with the need of psychooncological support. Beneficial factors that helped patients and caregivers cope with the illness included mutual respect, good communication, caregiver mastery and resilience. CONCLUSIONS: For a more comprehensive understanding of patient-caregiver interactions, we recommend using a combination of standardized psychometric tests and a semi-structured interview. The high percentage of emotional strain and depression found in patients and their caregivers facing HGG highlights the necessity of methodical screening for warning signs and consequent initiation of psycho-oncological interventions.
Entities:
Keywords:
Cancer caregiver; High-grade glioma; Oncology; Patient–caregiver relationship; Quality of life; Semi-structured interview
Authors: Kara Zivin Bambauer; Baohui Zhang; Paul K Maciejewski; Neayka Sahay; William F Pirl; Susan D Block; Holly G Prigerson Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2006-07-24 Impact factor: 4.328
Authors: Joanna Sierpowska; Adrià Rofes; Kristoffer Dahlslätt; Emmanuel Mandonnet; Mark Ter Laan; Monika Połczyńska; Philip De Witt Hamer; Matej Halaj; Giannantonio Spena; Torstein R Meling; Kazuya Motomura; Andrés Felipe Reyes; Alexandre Rainha Campos; Pierre A Robe; Luca Zigiotto; Silvio Sarubbo; Christian F Freyschlag; Martijn P G Broen; George Stranjalis; Konstantinos Papadopoulos; Evangelia Liouta; Geert-Jan Rutten; Catarina Pessanha Viegas; Ana Silvestre; Federico Perrote; Natacha Brochero; Cynthia Cáceres; Agata Zdun-Ryżewska; Wojciech Kloc; Djaina Satoer; Olga Dragoy; Marc P H Hendriks; Juan C Alvarez-Carriles; Vitória Piai Journal: Neurooncol Pract Date: 2022-04-04